IP Library Granted Patent US 9,241,975
Granted Patent B2
US 9,241,975 · App. 13/206,174 · Granted Jan 26, 2016

Reelin rescues congnitive function

Inventors: Edwin Weeber (Apollo Beach, FL); Lisa Zhao (Alhambra, CA); Melinda Peters (Riverview, FL)
Assignees: University of South Florida; Vanderbilt University
A61K38/1709A61K38/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,241,975
App. No.
13/206,174
Granted
Jan 26, 2016
Kind
B2
Abstract

Disclosed are methods of influencing, and enhancing, cognitive function by increasing, and/or preventing interference with, Reelin levels as well as Reelin signaling. Cognitive function is improved, in a subject in need thereof, by administering a therapeutically effective amount of Reelin, a Reelin-specific modulator or an agonist of a lipoprotein receptor to the subject. The lipoprotein receptor can be selected from candidates such as ApoER2 and VLDLR. As disclosed herein, agonists of the lipoprotein receptor for use with the inventive method include APC, Sep and Fc-RAP. In addition to administering exogenous Reelin, a Reelin-specific modulator, such as a recombinant Reelin fragment, can be used to increase Reelin levels and/or signaling.

Claims (4)

1. A method of improving associative learning and spatial learning and long term potentiation of neurons in a subject, comprising the step of administering a therapeutically effective amount of a 180 kDa Reelin protein fragment or a 370 kDa Reelin protein fragment to the subject;

where the improvement in associative learning and spatial learning is between 20% and 400% improvement and improvement in long term potentiation is between 20% and 46%; and

wherein the 180 kDa Reelin protein fragment or the 370 kDa Reelin protein fragment is administered into the ventricles of the subject.

2. The method of claim 1 , wherein the therapeutically effective amount of the 180 kDa Reelin protein fragment or the 370 kDa Reelin protein fragment is about 5 nM.

Assignments (5)
CONFIRMATORY LICENSE Recorded Jun 30, 2016
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039054/0591 →
CONFIRMATORY LICENSE Recorded Jan 8, 2013
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029585/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2012
From: ZHAO, LISA
To: VANDERBILT UNIVERSITY
Reel/Frame 027728/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2012
From: WEEBER, EDWIN
To: UNIVERSITY OF SOUTH FLORIDA; VANDERBILT UNIVERSITY
Reel/Frame 027728/0404 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2012
From: PETERS, MELINDA
To: UNIVERSITY OF SOUTH FLORIDA
Reel/Frame 027728/0408 →
Continuity (3)
Continuation PCTUS2010023615 · Feb 9, 2010
Provisional Application 61150890 · Feb 9, 2009
Related Publication 20120058109A1 · Mar 8, 2012